Atlas Trials

Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir

Clinical trial NCT06000657 · COMPLETED

Trial details

NCT number
NCT06000657
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2023-08-28
Primary completion
2025-02-03
Enrollment
196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.